Percutaneous Coronary Intervention (PCI) Causes

June 26, 2015 –  The following is good news for patients who will need percutaneous coronary intervention (PCI), however, bleeding problems are not completely resolved. But see for yourself. The U.S. Food and Drug Administration just approved Cangrelor (Kengreal), an intravenous antiplatelet …

Cangrelor (Kengreal) a newly approved antiplatelet drug used during PCI heart procedure Read more »